DC Chemicals Limited
China
Product Name: PSB-0739
Price: ￥Inquiry/100mg ￥Inquiry/250mg ￥Inquiry/1g
Purity: 98.0%
Stocking Period: 1 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

1052087-90-7

1052087-90-7 structure

Name: PSB 0739
Chemical Name: Disodium 1-amino-4-[(4-anilino-3-sulfonatophenyl)amino]-9,10-diox o-9,10-dihydro-2-anthracenesulfonate
CAS Number: 1052087-90-7
Molecular Formula: C₂₆H₁₇N₃Na₂O₈S₂
Molecular Weight: 609.54
Catalog: Signaling Pathways GPCR/G Protein P2Y Receptor
Create Date: 2016-11-27 07:45:21
Modify Date: 2025-08-20 11:32:02
PSB-0739 is a high-affinity potent, competitive, nonselective platelet P2Y12 receptor antagonist with a Ki values of 24.9 nM. The P2Y12 receptor plays a crucial role in platelet aggregation. Antithrombotic effect[1].

Name	Disodium 1-amino-4-[(4-anilino-3-sulfonatophenyl)amino]-9,10-diox o-9,10-dihydro-2-anthracenesulfonate

Description	PSB-0739 is a high-affinity potent, competitive, nonselective platelet P2Y12 receptor antagonist with a Ki values of 24.9 nM. The P2Y12 receptor plays a crucial role in platelet aggregation. Antithrombotic effect[1].
Related Catalog	Research Areas >> Cardiovascular Disease Signaling Pathways >> GPCR/G Protein >> P2Y Receptor
In Vitro	PSB-0739 is a potent competitive non-nucleotide antagonist at the human P2Y12 receptor with a pA2 value of 9.8[2]. PSB-0739 inhibits ADP-evoked Ca2+ responses with an EC50 of 5.4±1.8 μM and causes a rightward parallel shift in the ADP concentration–response curve in THP-1 cells[3]. Cell Viability Assay[3] Cell Line: THP-1 monocytic cell line Concentration: 10 nM, 100 nM, 1 μM, 10 μM Incubation Time: Result: Attenuated ADP-evoked responses (IC50=5.4±1.8 μM).
In Vivo	PSB-0739 (0.01-0.3 mg/kg, intrathecally) has dose-dependent and significant antihyperalgesic effect in low doses. The minimal effective dose (mED) is 0.1 mg/kg[4]. Animal Model: Male Wistar rats, 150-250 g, 6-8/group[4] Dosage: 0.01, 0.03, 0.1, 0.3 mg/kg Administration: Intrathecal injection ( i.t.) Result: Displayed a dose-dependent inhibitory effect on mechanical hyperalgesia in the range of 0.01–0.1 mg/kg.
References	[1]. Younis Baqi, et al. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y₁₂ receptors. J Med Chem. 2009 Jun 25;52(12):3784-93. [2]. Kristina Hoffmann, et al. Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y₁₂ receptor. J Pharmacol Exp Ther. 2009 Nov;331(2):648-55. [3]. J J Micklewright,et al. P2Y 12 receptor modulation of ADP-evoked intracellular Ca²⁺ signalling in THP-1 human monocytic cells. Br J Pharmacol.2018 Jun;175(12):2483-2491. [4]. Gergely Horváth, et al. Central P2Y₁₂ receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiol Dis. 2014 Oct;70(100):162-78.

Molecular Formula	C₂₆H₁₇N₃Na₂O₈S₂
Molecular Weight	609.54
Exact Mass	609.02500
PSA	215.38000
LogP	6.22840

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1052087-90-7	1052089-16-3
72255-76-6	1802226-88-5
1627710-30-8	1802226-87-4
1092351-10-4	409344-71-4
1399049-81-0	2332835-02-4
2309775-32-2	2194844-37-4
2309574-61-4	2320955-80-2
2309800-40-4	1367001-38-4
2319838-67-8	2319838-96-3
2185590-45-6	2309777-99-7